Multiple Sclerosis

Use of subjective minimizing terminology, such as “safe” and “tolerable,” when discussing treatment-related toxicities occurs frequently at oncology and hematology conferences, according to a study published in Journal of Cancer Policy.

Patient-reported outcome scores effectively predicted clinical and health-economic outcomes in adults with autosomal dominant polycystic kidney disease, a study found.

Editor’s note: Saturday, Feb. 3, is National Women Physicians Day, which is observed each year to honor the achievements and contributions of female physicians in health care.

Men with low-risk prostate cancer chose active surveillance more often than surgery or radiation when urologists recommended that course of action, according to study results published in Cancer.

A higher frequency of adding salt to food may be associated with an increased risk of chronic kidney disease in the general population, according to a recently published study.

Wafik S. El-Deiry, MD, PhD, FACP, has been elected chair of the Worldwide Innovative Networking (WIN) in Personalized Cancer Medicine Association — WIN Consortium.

Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Elizabeth Ward, MS, RDN, and Hillary Wright, MEd, RDN, LDN, about women’s nutrition and exercise needs as they age.

CMS levied fines for poor performance in the first year of its End-Stage Renal Disease Treatment Choices model against dialysis clinics with higher proportions of patients at social risk, a recently published study shows.

Healio has compiled a list of its most-read nephrology care news in 2023.

A biotechnology company announced the first patient was dosed in its phase 2a clinical trial of intranasal foralumab, a monoclonal antibody treatment for those with non-active secondary-progressive multiple sclerosis.